Polymyositis and Dermatomyositis
Open Access
- 20 February 1975
- journal article
- review article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 292 (8), 403-407
- https://doi.org/10.1056/nejm197502202920807
Abstract
(Second of Two Parts)Laboratory FeaturesElevation of sarcoplasmic enzymes in serum (creatine phosphokinase, aldolase, transaminases and lactic dehydrogenase) is valuable both for diagnosis and for following the clinical activity and response to treatment. Although some state that the transaminases are the most reliable,31,33,35 most authorities favor the creatine phosphokinase.2 These serum enzymes are not infallible guidelines, for occasionally they remain entirely within the normal range despite active myositis1,51; likewise, when muscle atrophy is extensive in long standing disease, the enzymes may be normal despite active myositis. Motor-neuron diseases, Duchenne muscular dystrophy and other dystrophies, metabolic disorders, endocrinopathies, toxins . . .Keywords
This publication has 42 references indexed in Scilit:
- Prognosis in childhood dermatomyositisThe Journal of Pediatrics, 1972
- Experimental allergic myositis in ratsArthritis & Rheumatism, 1971
- Necrosis of muscle with carcinoma: myositis or myopathy?Journal of Neurology, Neurosurgery & Psychiatry, 1970
- Skeletal muscle necrosis associated with carcinomaThe Journal of Pathology, 1969
- DERMATOMYOSITIS AND CARCINOMABritish Journal of Dermatology, 1968
- DermatomyositisThe Journal of Pediatrics, 1964
- Some further uses of antibodies for analyzing the structure and development of muscle*1Experimental Cell Research, 1959
- SCLERODERMA AND DERMATOMYOSITIS.*British Journal of Dermatology, 1955
- DERMATOMYOSITIS AND MALIGNANT TUMOURBritish Journal of Dermatology, 1946
- DermatomyositisArchives of Dermatological Research, 1935